---
figid: PMC7400218__ol-20-03-2058-g05
figlink: .na.character
number: F5
caption: TLR4 signaling pathways in cervical cancer. (A) Binding of LPS to TLR4 leads
  to the transmission of signals via MyD88, At the same time the activation of TLR5
  leads to increased Nox1 signaling. The primary role of NOX1 is to generate ROS.
  NOX1 signaling also leads to the inhibition of HIF-1α degradation, which increases
  the possibly of developing cervical cancer MyD88 signaling in conjunction with NOX1
  leads to the activation of transcription factors and Interfrons (IFN), leading to
  a pro-inflammatory and antiviral response. This pathway demonstrates how inflammation
  can lead to cancer progression. CD1, cluster differentiation 1; HIF-1α, hypoxia
  inducible factor 1α; IL-6, interleukin 6; IFN, interferon; IRAK, interleukin-1 receptor-associated
  kinase; IRF3, interferon regulatory factor 3; LPS, lipopolysaccharides; MyD8, myeloid
  differentiation primary response 8; MyD88, myeloid differentiation primary response
  88; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; Nox1,
  NADPH oxidase 1; PHDs, propyl hydroxylases; Rac1, ras-related C3 botulinum toxin
  substrate 1; TAK1, transforming growth factor beta-activated kinase 1; TLR, toll-like
  receptor; Traf6, tumor necrosis factor receptor (TNFR)-associated factor 6; NADH,
  nicotinamide adenine dinucleotide hydrogen.
pmcid: PMC7400218
papertitle: Cervical cancer in low and middle-income countries.
reftext: Rodney Hull, et al. Oncol Lett. 2020 Sep;20(3):2058-2074.
pmc_ranked_result_index: '6753'
pathway_score: 0.9681259
filename: ol-20-03-2058-g05.jpg
figtitle: Cervical cancer in low and middle-income countries
year: '2020'
organisms:
- Mus musculus
- Human alphaherpesvirus 2
- Human papillomavirus
- Human immunodeficiency virus
- Human papillomavirus types
- DNA viruses
- Human papillomavirus type 16
- Nicotiana tabacum
- Chlamydia trachomatis
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7400218__ol-20-03-2058-g05.html
  '@type': Dataset
  description: TLR4 signaling pathways in cervical cancer. (A) Binding of LPS to TLR4
    leads to the transmission of signals via MyD88, At the same time the activation
    of TLR5 leads to increased Nox1 signaling. The primary role of NOX1 is to generate
    ROS. NOX1 signaling also leads to the inhibition of HIF-1α degradation, which
    increases the possibly of developing cervical cancer MyD88 signaling in conjunction
    with NOX1 leads to the activation of transcription factors and Interfrons (IFN),
    leading to a pro-inflammatory and antiviral response. This pathway demonstrates
    how inflammation can lead to cancer progression. CD1, cluster differentiation
    1; HIF-1α, hypoxia inducible factor 1α; IL-6, interleukin 6; IFN, interferon;
    IRAK, interleukin-1 receptor-associated kinase; IRF3, interferon regulatory factor
    3; LPS, lipopolysaccharides; MyD8, myeloid differentiation primary response 8;
    MyD88, myeloid differentiation primary response 88; NF-κB, nuclear factor kappa-light-chain-enhancer
    of activated B cells; Nox1, NADPH oxidase 1; PHDs, propyl hydroxylases; Rac1,
    ras-related C3 botulinum toxin substrate 1; TAK1, transforming growth factor beta-activated
    kinase 1; TLR, toll-like receptor; Traf6, tumor necrosis factor receptor (TNFR)-associated
    factor 6; NADH, nicotinamide adenine dinucleotide hydrogen.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - CD1A
  - MYD88
  - RAC1
  - IRAK1
  - HIF1A
  - IRF3
  - TRAF6
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF5
  - TRAF4
  - TRAF7
  - MAP3K7CL
  - NR2C2
  - AK1
  - EIF5B
  - TNF
  - IL6
  - NELFCD
  - CYBB
  - TLR4
  - LPS
  - MYD88 00000000000_ 00000000000
  - cancer
genes:
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: CD1
  symbol: CD1
  source: hgnc_prev_symbol
  hgnc_symbol: CD1A
  entrez: '909'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: CD1
  symbol: CD1
  source: hgnc_prev_symbol
  hgnc_symbol: CD1A
  entrez: '909'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: IRAK
  symbol: IRAK
  source: hgnc_alias_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: HIF1-a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF1
  entrez: '7185'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF4
  entrez: '9618'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF7
  entrez: '84231'
- word: ТАК1
  symbol: TAKL
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K7CL
  entrez: '56911'
- word: ТАК1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: ТАК1
  symbol: AK1
  source: hgnc_symbol
  hgnc_symbol: AK1
  entrez: '203'
- word: HIF1-a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: IFII
  symbol: IF2
  source: hgnc_alias_symbol
  hgnc_symbol: EIF5B
  entrez: '9669'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: NOX2
  symbol: NOX2
  source: hgnc_alias_symbol
  hgnc_symbol: CYBB
  entrez: '1536'
- word: NOX2
  symbol: NOX2
  source: hgnc_alias_symbol
  hgnc_symbol: CYBB
  entrez: '1536'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
chemicals: []
diseases:
- word: LPS
  source: MESH
  identifier: C536528
- word: MYD88 00000000000_ 00000000000
  source: MESH
  identifier: C567379
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7400218__F5
redirect_from: /figures/PMC7400218__F5
figtype: Figure
---
